
Prime Multi-Speciality Healthcare And Research Private Limited
Provides hospital and medical services under Prime Medical Center.
Provides hospital and medical services under Prime Medical Center.
Prime Multi-Speciality Healthcare And Research Private Limited (PMHARPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2010 and has a history of 14 years and seven months. Its registered office is in Bilaspur, Chattisgarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.61 Cr.
The company currently has active open charges totaling ₹3.90 M.
Nitin Juneja, Nidhi Juneja, Sanat Jain, and Two other members serve as directors at the Company.
Bilaspur, Chattisgarh, India
+91-XXXXXXXXXX
-
U85110CT2010PTC021956
021956
Private Limited Indian Non-Government Company
20 Jul 2010
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chhattisgarh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitin Juneja ![]() | Managing Director | 20-Jul-2010 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nidhi Juneja ![]() | Whole-Time Director | 20-Jul-2010 | Current |
Sanat Jain ![]() | Whole-Time Director | 20-Jul-2010 | Current |
Rahul Chhabra ![]() | Director | 20-Jul-2010 | Current |
Lalit Makhija ![]() | Director | 19-Jul-2021 | Current |
Prime Multi-Speciality Healthcare And Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.43% increase in profit. The company's net worth dipped by a decrease of 0.83%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Prime Multi-Speciality Healthcare And Research had a promoter holding of 52.33% and a public holding of 47.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rahul Chhabra is a mutual person
Lalit Makhija is a mutual person
₹0.39 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
15 Mar 2012 | State Bank Of India | ₹3.90 M | Open |
Unlock and access historical data on people associated with Prime Multi-Speciality Healthcare And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Prime Multi-Speciality Healthcare And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Multi-Speciality Healthcare And Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Prime Multi-Speciality Healthcare And Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Prime Multi-Speciality Healthcare And Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chhattisgarh.
Lalit Nanak Makhija was appointed as a Director was appointed as a Director on 19 Jul 2021 & has been associated with this company since 3 years 7 months .
A charge with State Bank Of India amounted to Rs. 0.39 Cr with Charge ID 10341700 was registered on 15 Mar 2012.
Rahul Chhabra was appointed as a Director was appointed as a Director on 20 Jul 2010 & has been associated with this company since 14 years 7 months .
Nitin Juneja was appointed as a Managing Director was appointed as a Managing Director on 20 Jul 2010 & has been associated with this company since 14 years 7 months .
Prime Multi-Speciality Healthcare And Research Private Limited was incorporated on 20 Jul 2010.
The authorized share capital of Prime Multi-Speciality Healthcare And Research Private Limited is ₹ 3.50 Cr and paid-up capital is ₹ 2.61 Cr.
Currently 5 directors are associated with Prime Multi-Speciality Healthcare And Research Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Prime Multi-Speciality Healthcare And Research Private Limited is C/O Melaram And Brothers Telipara India, Bilaspur, Chattisgarh, 495001.
The corporate identification number (CIN) of Prime Multi-Speciality Healthcare And Research Private Limited is U85110CT2010PTC021956 and the company number is 021956 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2023 indicates that The net worth of Prime Multi-Speciality Healthcare And Research Private Limited has experienced an downturn of -0.83%.
As per the financial statements for fiscal Year 2023, The total open charges for Prime Multi-Speciality Healthcare And Research Private Limited amount to ₹ 3.90 M.
The most recent Balance Sheet for Prime Multi-Speciality Healthcare And Research Private Limited was filed with the ROC on 31 Mar 2023.
PP
ND